AUS
NZ
UK
CA
USA
IND
Highlights
- Trulieve Cannabis Corp. operates as a vertically integrated medical cannabis company across multiple U.S. states.
- The company completed its uplisting to the New York Stock Exchange under the ticker TRLV in June 2026.
- Retail operations, cultivation facilities, branded products, and medical cannabis programs remain central to the business.
The healthcare sector continues to attract attention as regulated medical cannabis businesses expand their operational footprint across the United States. Within the context of the NYSE Composite, Trulieve Cannabis Corp. (NYSE:TRLV) represents a vertically integrated cannabis operator focused on cultivation, processing, manufacturing, distribution, and retail dispensary operations. The company's transition to the New York Stock Exchange marked an important milestone in its corporate development while expanding its presence within the U.S. public equity market.
Business operations
The company maintains an integrated operating model that combines cannabis cultivation, manufacturing, product development, distribution, and dispensary operations. This structure allows production and retail activities to function within regulated state medical cannabis programs while maintaining quality standards across different stages of the supply chain.
Operations include cultivation facilities, processing centers, manufacturing locations, distribution networks, and medical cannabis dispensaries serving eligible patients in multiple jurisdictions. The company also supports home delivery services where permitted under applicable regulations.
Geographic presence
Florida remains a significant operating market, while business activities also extend across Georgia, Pennsylvania, West Virginia, Arizona, Maryland, Connecticut, and Ohio. Cultivation and manufacturing infrastructure supports retail operations throughout these regulated medical cannabis markets.
Expansion into multiple jurisdictions reflects the varying regulatory frameworks governing medical cannabis programs across the United States. Each state maintains separate licensing requirements, operating standards, product rules, and patient eligibility criteria, creating distinct operating environments for cannabis businesses.
Product portfolio
The company offers a broad range of cannabis products that includes dried flower, concentrates, vaporizer products, edibles, oral formulations, topical products, accessories, and branded offerings developed for medical cannabis patients. Several product brands support different consumer preferences and medical program requirements across participating states.
Product development remains an important component of the business as regulated cannabis markets continue introducing new product formats within state-specific legal frameworks. Manufacturing operations emphasize standardized production processes, packaging compliance, laboratory testing, and distribution through licensed retail locations.
NYSE listing
A notable corporate development occurred during June 2026 when the company completed its uplisting to the New York Stock Exchange under the ticker symbol TRLV. The listing followed corporate restructuring activities designed to support eligibility for the exchange while maintaining operations centered on regulated medical cannabis programs.
The NYSE listing represented a significant milestone for the regulated cannabis industry in the United States because it broadened the company's visibility within public equity markets. Trading under the TRLV symbol also aligned the company with broader discussions surrounding healthcare businesses and regulated cannabis enterprises participating within the NYSE Composite.
Industry environment
Medical cannabis remains one of the more closely regulated segments within the healthcare industry. Businesses operating in this area must comply with licensing requirements, cultivation standards, manufacturing regulations, inventory tracking systems, product testing procedures, packaging requirements, and patient access rules established by state authorities.
The regulatory landscape continues evolving as additional states refine medical cannabis programs and adjust operational requirements. Changes in federal classification during 2026 also influenced the regulatory environment surrounding medical cannabis businesses, contributing to developments that supported the company's NYSE uplisting.
Operational structure and market category
Trulieve operates within the regulated cannabis industry, a segment often classified among Cannabis Stocks due to its focus on cultivation, processing, manufacturing, and retail distribution of cannabis products. The company’s vertically integrated structure allows control across several stages of production, from plant cultivation to finished products available through licensed dispensaries.
The business model is designed around state-regulated medical cannabis programs, requiring compliance with licensing standards, testing procedures, inventory tracking requirements, and distribution rules. These regulations create a framework where operators must maintain operational consistency across cultivation sites, manufacturing facilities, and retail locations.
The company’s dispensary network serves registered medical cannabis patients in multiple states, with Florida representing a significant part of its operating footprint. Additional operations include locations such as Georgia, Pennsylvania, and West Virginia, where medical cannabis programs have established specific requirements for operators and patients.
Retail and production network
Retail operations remain a core component of Trulieve’s business activities. The company manages dispensaries that provide access to cannabis products approved under state medical programs. These locations support patient education, product availability, and regulated distribution.
Behind the retail network, cultivation and manufacturing infrastructure supports product supply. The company’s production facilities handle activities including growing cannabis plants, processing harvested material, creating finished products, packaging, and preparing items for distribution through licensed channels.
This integrated approach connects production capabilities with retail operations, allowing the company to manage multiple stages of the supply chain. Such structures are common among large cannabis operators seeking control over product quality, consistency, and availability.
Product development and brands
Trulieve’s product portfolio includes flower, concentrates, vapor products, edibles, tinctures, topical products, and other cannabis-based items. Product offerings are developed according to state regulations, which determine available formats, labeling requirements, testing standards, and distribution rules.
Branded products represent an important part of the company’s consumer-facing activities. Through product development and retail presentation, the company maintains recognition among medical cannabis customers across different state programs.
The regulated nature of the cannabis sector means product categories and availability can vary significantly between states. Each jurisdiction establishes separate rules regarding approved products, possession limits, purchase procedures, and patient qualifications.
Industry position and public market presence
The company’s NYSE listing under TRLV placed its shares within a major U.S. exchange environment. The listing began trading on June 10, 2026, following approval from the New York Stock Exchange.
The move placed the company within broader discussions surrounding publicly traded cannabis businesses and their participation in regulated financial markets. Within the context of the NYSE Composite, the listing connects Trulieve with a broad group of companies across multiple industries represented on the exchange.
The company continues operating in a specialized industry where regulatory developments, state-level programs, healthcare trends, and consumer demand patterns influence business conditions.
Regulatory environment
Cannabis businesses operate under a complex regulatory framework because cannabis laws differ between federal and state jurisdictions. State medical cannabis programs establish requirements covering licensing, cultivation, manufacturing, distribution, and retail activities.
Trulieve’s operations are focused on licensed medical cannabis markets, requiring adherence to state-specific compliance standards. These requirements influence how facilities operate, how products move through supply chains, and how dispensaries interact with registered patients.
The regulatory environment remains an important part of understanding the company’s business activities. Changes in legislation, licensing structures, or government classification can affect the broader cannabis industry landscape.
